
TransMedics Group TMDX
$ 85.17
-9.47%
TransMedics Group Operating Income | TMDX
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income TransMedics Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109 M | 37.5 M | -28.7 M | -31.4 M | -39.4 M | -26.4 M | -29.6 M | -20.2 M | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 109 M | -39.4 M | -3.72 M |
Quarterly Operating Income TransMedics Group
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.1 M | 23.7 M | 13.3 M | 21.3 M | 23.3 M | 36.6 M | 27.4 M | 8.64 M | 3.92 M | 12.5 M | 12.4 M | 2.6 M | -28.3 M | -906 K | -2.09 M | -6.78 M | -5.54 M | -9.74 M | -9.37 M | -11.3 M | -11.7 M | -9.87 M | -6.51 M | -5.9 M | -4.61 M | -7.86 M | -8.02 M | -8.69 M | -7.24 M | -7.7 M | -5.96 M | -6.36 M | -3.94 M | -5.16 M | -4.78 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 36.6 M | -28.3 M | 1.01 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
EDAP TMS S.A.
EDAP
|
-20.5 M | - | - | $ 162 M | ||
|
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | ||
|
Zynex
ZYXI
|
5.99 M | - | - | $ 21.1 M | ||
|
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | ||
|
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M | ||
|
CONMED Corporation
CNMD
|
103 M | $ 46.69 | 0.39 % | $ 1.45 B | ||
|
ShockWave Medical
SWAV
|
159 M | - | - | $ 12.3 B | ||
|
Nevro Corp.
NVRO
|
-126 M | - | - | $ 217 M | ||
|
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | ||
|
Axonics Modulation Technologies
AXNX
|
-26.1 M | - | - | $ 3.31 B | ||
|
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | ||
|
ThermoGenesis Holdings
THMO
|
-8.61 M | - | -25.84 % | $ 171 K | ||
|
Talis Biomedical Corporation
TLIS
|
-66.8 M | - | 3.55 % | $ 7.96 M | ||
|
Abiomed
ABMD
|
141 M | - | - | $ 17.2 B | ||
|
Titan Medical
TMDI
|
-31 M | - | -26.32 % | $ 19.6 M | ||
|
SmileDirectClub
SDC
|
-262 M | - | -53.45 % | $ 9.71 M | ||
|
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | ||
|
Sientra
SIEN
|
-69 M | - | -16.59 % | $ 10.3 M | ||
|
Acutus Medical
AFIB
|
-57 K | - | -26.83 % | $ 2.62 M | ||
|
Viveve Medical
VIVE
|
-21.6 M | - | -15.35 % | $ 1.71 M | ||
|
MiMedx Group
MDXG
|
63.9 M | $ 3.06 | -1.77 % | $ 452 M | ||
|
Venus Concept
VERO
|
-27.2 M | - | - | $ 726 K | ||
|
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | ||
|
Surgalign Holdings
SRGA
|
-78.5 M | - | -32.98 % | $ 1.68 M | ||
|
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | ||
|
SeaSpine Holdings Corporation
SPNE
|
-61 M | - | 0.28 % | $ 270 M | ||
|
Inari Medical
NARI
|
-14 M | - | - | $ 4.23 B | ||
|
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | ||
|
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | ||
|
ViewRay
VRAY
|
-107 M | - | 1.54 % | $ 468 M | ||
|
Medigus Ltd.
MDGS
|
-8.02 M | - | 10.28 % | $ 55.5 M | ||
|
Abbott Laboratories
ABT
|
8.05 B | $ 103.08 | -0.98 % | $ 179 B | ||
|
Align Technology
ALGN
|
546 M | $ 154.77 | -3.07 % | $ 11.2 B | ||
|
Vapotherm
VAPO
|
-39.1 M | - | 6.72 % | $ 34 M | ||
|
Silk Road Medical, Inc
SILK
|
-59.3 M | - | - | $ 1.07 B | ||
|
Alphatec Holdings
ATEC
|
-82.1 M | $ 6.66 | -3.48 % | $ 999 M | ||
|
Boston Scientific Corporation
BSX
|
3.61 B | $ 41.95 | -2.43 % | $ 62.1 B | ||
|
Natus Medical Incorporated
NTUS
|
23.8 M | - | 1.94 % | $ 1.05 B | ||
|
Nemaura Medical
NMRD
|
-9.6 M | - | -17.8 % | $ 2.74 M | ||
|
Butterfly Network
BFLY
|
-86.4 M | $ 5.39 | -8.28 % | $ 1.33 B | ||
|
Bio-Rad Laboratories
BIO
|
47.2 M | $ 358.56 | -2.43 % | $ 9.78 B | ||
|
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 101.86 | -1.94 % | $ 59.6 B | ||
|
Aethlon Medical
AEMD
|
-7.29 M | $ 5.49 | 13.33 % | $ 3.7 M | ||
|
Apyx Medical Corporation
APYX
|
-6.45 M | $ 2.39 | 2.06 % | $ 98.2 M | ||
|
Cognyte Software Ltd.
CGNT
|
13.3 M | $ 7.27 | -6.56 % | $ 530 M | ||
|
Medtronic PLC
MDT
|
6.47 B | $ 99.64 | -1.0 % | $ 128 B |